返回
Simcere Pharmaceutical Group Limited（2096.HK）价格
2096.HK 股价走势图
SIMCERE PHARMA (2096.HK)
Simcere Pharmaceutical Group Limited
HK$11.58
0.08%
$0
盘中： Jan 20, 11:42:09 HKT
Simcere Pharmaceutical Group Limited 股息信息股息历史 股息图表
2096.HK 股息
2096.HK 股息增长率（同比）
Follow-Up Questions
Simcere Pharmaceutical Group Limited 当前的股息支付和年度股息是多少？
Simcere Pharmaceutical Group Limited 的股息支付比率是多少？
2096.HK 的除息日是什么？
Simcere Pharmaceutical Group Limited 多久支付一次股息？
关键数据
前收盘价
$11.6
开盘价
$11.57
当日区间
$11.49 - $11.74
52周范围
$6.6 - $15.08
交易量
632.0K
平均成交量
8.5M
每股收益（TTM）
0.40
股息收益率
--
市值
$30.0B
什么是 SIMCERE PHARMA？
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.